495 related articles for article (PubMed ID: 16712945)
1. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries.
Rihmer Z; Akiskal H
J Affect Disord; 2006 Aug; 94(1-3):3-13. PubMed ID: 16712945
[TBL] [Abstract][Full Text] [Related]
2. Pediatric prescribing practices and the FDA Black-box warning on antidepressants.
Cheung A; Sacks D; Dewa CS; Pong J; Levitt A
J Dev Behav Pediatr; 2008 Jun; 29(3):213-5. PubMed ID: 18550990
[TBL] [Abstract][Full Text] [Related]
3. Psychopharmacology. FDA weighs suicide risk in children on antidepressants.
Holden C
Science; 2004 Feb; 303(5659):745. PubMed ID: 14764841
[No Abstract] [Full Text] [Related]
4. Antidepressants use in pediatric populations.
Gören JL
Expert Opin Drug Saf; 2008 May; 7(3):223-5. PubMed ID: 18462180
[TBL] [Abstract][Full Text] [Related]
5. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
Akiskal HS; Benazzi F
J Affect Disord; 2006 Aug; 94(1-3):105-10. PubMed ID: 16766043
[TBL] [Abstract][Full Text] [Related]
6. Antidepressants and suicidality: the basis of controversies.
Marcinko D
Psychiatr Danub; 2007 Sep; 19(3):238-40. PubMed ID: 17914327
[TBL] [Abstract][Full Text] [Related]
7. How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?
Hall WD; Lucke J
Aust N Z J Psychiatry; 2006; 40(11-12):941-50. PubMed ID: 17054562
[TBL] [Abstract][Full Text] [Related]
8. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
Hjalmarsson L; Corcos M; Jeammet P
Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
[TBL] [Abstract][Full Text] [Related]
9. [SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].
Tandt H; Audenaert K; van Heeringen C
Tijdschr Psychiatr; 2009; 51(6):387-93. PubMed ID: 19517368
[TBL] [Abstract][Full Text] [Related]
10. Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs.
Morrato EH; Libby AM; Orton HD; Degruy FV; Brent DA; Allen R; Valuck RJ
Am J Psychiatry; 2008 Jan; 165(1):42-50. PubMed ID: 17986680
[TBL] [Abstract][Full Text] [Related]
11. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.
Valuck RJ; Libby AM; Orton HD; Morrato EH; Allen R; Baldessarini RJ
Am J Psychiatry; 2007 Aug; 164(8):1198-205. PubMed ID: 17671282
[TBL] [Abstract][Full Text] [Related]
12. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
13. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
14. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
[TBL] [Abstract][Full Text] [Related]
15. Suicide behaviour of patients treated with antidepressants.
Rihmer Z; Gonda X
Neuropsychopharmacol Hung; 2006 Mar; 8(1):13-6. PubMed ID: 16841560
[TBL] [Abstract][Full Text] [Related]
16. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs.
Libby AM; Brent DA; Morrato EH; Orton HD; Allen R; Valuck RJ
Am J Psychiatry; 2007 Jun; 164(6):884-91. PubMed ID: 17541047
[TBL] [Abstract][Full Text] [Related]
17. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.
Gibbons RD; Brown CH; Hur K; Marcus SM; Bhaumik DK; Erkens JA; Herings RM; Mann JJ
Am J Psychiatry; 2007 Sep; 164(9):1356-63. PubMed ID: 17728420
[TBL] [Abstract][Full Text] [Related]
18. Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review.
Möller HJ
Eur Arch Psychiatry Clin Neurosci; 2006 Dec; 256(8):476-96. PubMed ID: 17143567
[TBL] [Abstract][Full Text] [Related]
19. Use of selective serotonin reuptake inhibitors in children and adolescents.
Wong IC; Besag FM; Santosh PJ; Murray ML
Drug Saf; 2004; 27(13):991-1000. PubMed ID: 15471506
[TBL] [Abstract][Full Text] [Related]
20. Review of the efficacy and safety of antidepressants in youth depression.
Cheung AH; Emslie GJ; Mayes TL
J Child Psychol Psychiatry; 2005 Jul; 46(7):735-54. PubMed ID: 15972068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
